Cargando…

165 Rates of SGLT2 Inhibitor Use in Patients With Diabetes and Heart Failure in the Southeastern United States

OBJECTIVES/GOALS: Clinical trials of SGLT2 inhibitors in patients with heart failure (HF) have confirmed a reduction in hospitalization and death. Adoption of novel therapeutics has been slower in Black and female patients. We investigated utilization of SGLT2 inhibitor in patients with HF and type...

Descripción completa

Detalles Bibliográficos
Autores principales: Gangavelli, Apoorva, Liu, Zihao, Wang, Jeffrey, Okoh, Alexis, Patel, Shivani, Morris, Alanna A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209126/
http://dx.doi.org/10.1017/cts.2022.73

Ejemplares similares